We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
Cap. Flow
+$235M
Cap. Flow %
3.1%
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$71M
2
BAX icon
Baxter International
BAX
+$60.7M
3
TMUS icon
T-Mobile US
TMUS
+$60.1M
4
PRGO icon
Perrigo
PRGO
+$53.7M
5
NRG icon
NRG Energy
NRG
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.11%
2 Industrials 11.84%
3 Consumer Discretionary 11.65%
4 Technology 10.61%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTWO icon
151
Take-Two Interactive
TTWO
$44.9B
$14M 0.18%
498,511
+487,922
+4,608% +$12.5M
JNJ icon
152
Johnson & Johnson
JNJ
$614B
$14M 0.18%
133,478
-127,130
-49% -$13.4M
AKAM icon
153
Akamai
AKAM
$17.9B
$13.7M 0.18%
217,642
+209,719
+2,647% +$12.6M
SNDK
154
DELISTED
SANDISK CORP
SNDK
$13.6M 0.18%
138,797
-294,280
-68% -$28.1M
SIRO
155
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$13.5M 0.18%
154,662
+17,277
+13% +$1.43M
BURL icon
156
Burlington
BURL
$23.2B
$13.3M 0.18%
+282,459
New +$12M
AXTA icon
157
Axalta
AXTA
$8.05B
$13.3M 0.18%
+509,781
New +$12.6M
PCYC
158
DELISTED
PHARMACYCLICS INC
PCYC
$13.2M 0.17%
+108,227
New +$13.8M
MRO
159
DELISTED
Marathon Oil Corporation
MRO
$13.2M 0.17%
465,769
+423,248
+995% +$13.5M
FWONA icon
160
Liberty Media Series A
FWONA
$22.2B
$13.1M 0.17%
552,949
-35,480
-6% -$837K
RVBD
161
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$12.4M 0.16%
609,485
-422,437
-41% -$8.11M
SR icon
162
Spire
SR
$4.7B
$12.3M 0.16%
231,285
-236,550
-51% -$11.9M
CLR
163
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$12.3M 0.16%
319,949
+314,565
+5,843% +$15.5M
AVNS
164
DELISTED
Avanos Medical
AVNS
$12.2M 0.16%
+267,953
New +$10.5M
ALLY icon
165
Ally Financial
ALLY
$13.7B
$12.2M 0.16%
+515,517
New +$11.7M
SPG icon
166
Simon Property Group
SPG
$73.3B
$12.1M 0.16%
66,569
+16,746
+34% +$2.97M
AVNT icon
167
Avient
AVNT
$3.5B
$12.1M 0.16%
317,931
-1,250,971
-80% -$45.7M
MRVL icon
168
Marvell Technology
MRVL
$196B
$12M 0.16%
830,663
+231,082
+39% +$3.14M
ASB icon
169
Associated Banc-Corp
ASB
$5.99B
$12M 0.16%
644,452
+606,394
+1,593% +$11.1M
CVD
170
DELISTED
COVANCE INC.
CVD
$11.8M 0.16%
113,434
-84,399
-43% -$7.91M
FOSL icon
171
Fossil Group
FOSL
$360M
$11.8M 0.16%
+106,259
New +$11.1M
NWS icon
172
News Corp Class B
NWS
$17.7B
$11.7M 0.16%
+779,012
New +$11.7M
QIWI
173
DELISTED
QIWI PLC
QIWI
$11.7M 0.15%
578,671
-452,292
-44% -$12.3M
DXCM icon
174
DexCom
DXCM
$32.8B
$11.7M 0.15%
+847,064
New +$10.4M
HAL icon
175
Halliburton
HAL
$27B
$11.6M 0.15%
295,742
+25,010
+9% +$1.22M

Similar funds

Marshall Wace's Q4 2014 Portfolio in Review

As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.

  • Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
  • Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
  • Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
  • Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
  • Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
  • Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
  • Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.

Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.